In conjunction with the announcement on Friday February 17, 2012 of AMT’s Business being acquired by uniQure BV, we are pleased to invite you to our company on March 20, 2012 from 17.00 – 19.00 at AMT, 61 Meibergdreef in Amsterdam for an informational meeting on the transaction. During...

During this meeting, Ferdinand Verdonck head of the Special Committee for the evaluation of the transaction, Jörn Aldag (CEO), Piers Morgan (CFO) Dr. Carlos Camozzi (Chief Medical Officer) will be on hand to answer investor questions.

You can sign up for this meeting by sending an...

Extraordinary General Meeting of shareholders ("Extraordinary General Meeting") of Amsterdam Molecular Therapeutics (AMT) Holding N.V. ("AMT") to be held on Friday 30 March 2012 at 11:00 CET at Academisch Medisch Centrum, College Zaal 2, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands.

NVP Seminar, Amsterdam NL
Locatie Hermitage te Amsterdam